Childhood TB in Myanmar: trends in notification, profile and treatment outcomes in the private sector

S K Thein1, S Satyanarayana2, K W Y Kyaw3

  • 1Department of Medical Research, Yangon, Myanmar.

Public Health Action
|February 12, 2020
PubMed

Insights

Childhood tuberculosis (TB) notification rates are declining in Myanmar. The private sector plays a significant role, diagnosing and treating one in five cases with a high success rate.

Area of Science:

  • Public Health
  • Epidemiology
  • Tuberculosis Research

Background:

  • Childhood tuberculosis (TB) remains a significant global health concern.
  • Understanding trends and private sector involvement is crucial for effective control strategies.

Purpose of the Study:

  • To analyze trends in childhood TB notification in Myanmar from 2014-2017.
  • To quantify the private sector's contribution to childhood TB notification.
  • To describe the profile and treatment outcomes of childhood TB managed in the private sector.

Main Methods:

  • Observational study utilizing routine records and reports from Myanmar's National Tuberculosis (TB) programme (NTP) public-private mix (PPM) projects.
  • Data review from projects managed by the Myanmar Medical Association and Population Service International.

Main Results:

  • Childhood TB notifications declined from 36,314 in 2014 to 28,723 in 2017.
  • The private sector accounted for 17-19% of notifications.
  • Of 5616 childhood TB cases treated in PPM projects in 2016, 97.7% had successful outcomes.

Conclusions:

  • Childhood TB notification is decreasing in Myanmar.
  • The private sector is a vital component of TB case finding and management, demonstrating high treatment success rates.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
488
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
439
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
822
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
762
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K